Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Decoding alzheimers disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies
Research Tool: Valuable for exploring novel ERR-targeted therapies
Patients with high blood pressure should monitor for dizziness or blood pressure fluctuations during early treatment
These include those related to sexual health, weight loss, and more
July 2024: Roche reported early clinical data for CT-996, its once-daily oral GLP-1 receptor agonist, showing clinically meaningful weight loss after four weeks and supporting further development in obesity and type 2 diabetes
PMID: 8544049
)
US$ 28.23
US$ 21.42
US$ 24.08
